 The US government is moving to increase its use of artificial intelligence. Food and Drug Administration Commissioner Marty Makary outlined plans to use AI tools to speed up drug approvals, saying it could give “a first-pass review” of applications that can reach 500,000 pages long, and reduce delays from years to weeks. The FDA recently released an internal chatbot, Elsa, and launched “the first AI-assisted scientific review pilot,” Makary said. Separately, Washington will launch a website called ai.gov, 404 Media reported: Leaked code suggested it will “[push] AI tools into agencies across government.” But skepticism abounds. Elsa is “far from transformative,” The New York Times reported, and one recent government report was full of apparently AI-fabricated references. |